NUVEEN QUALITY MUNICIPAL INC (NAD)

US67066V1017

11.635  +0.13 (+1.17%)

After market: 11.41 -0.22 (-1.93%)

Fundamental Rating

3

NAD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. The financial health of NAD is average, but there are quite some concerns on its profitability. NAD has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year NAD was profitable.
NAD had a positive operating cash flow in the past year.
NAD had positive earnings in 4 of the past 5 years.
Each year in the past 5 years NAD had a positive operating cash flow.

1.2 Ratios

Industry RankSector Rank
ROA 0.04%
ROE 0.04%
ROIC 2.02%
ROA(3y)-3.99%
ROA(5y)-0.32%
ROE(3y)-4.3%
ROE(5y)-0.46%
ROIC(3y)2.16%
ROIC(5y)2.15%

1.3 Margins

NAD's Profit Margin has declined in the last couple of years.
NAD's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of NAD has declined.
Industry RankSector Rank
OM 58.4%
PM (TTM) 0.95%
GM 58.58%
OM growth 3Y-10.98%
OM growth 5Y-5.49%
PM growth 3Y-26.87%
PM growth 5YN/A
GM growth 3Y-10.95%
GM growth 5Y-5.5%

5

2. Health

2.1 Basic Checks

The number of shares outstanding for NAD remains at a similar level compared to 1 year ago.
The number of shares outstanding for NAD has been increased compared to 5 years ago.
Compared to 1 year ago, NAD has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 12.82 indicates that NAD is not in any danger for bankruptcy at the moment.
The Debt to FCF ratio of NAD is 0.32, which is an excellent value as it means it would take NAD, only 0.32 years of fcf income to pay off all of its debts.
NAD has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Even though the debt/equity ratio score it not favorable for NAD, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.32
Altman-Z 12.82
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

NAD has a Current Ratio of 2.73. This indicates that NAD is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.73 indicates that NAD has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.73

2

3. Growth

3.1 Past

NAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 105.18%, which is quite impressive.
The earnings per share for NAD have been decreasing by -27.71% on average. This is quite bad
The Revenue has been growing slightly by 3.63% in the past year.
The Revenue has been growing slightly by 1.26% on average over the past years.
EPS 1Y (TTM)105.18%
EPS 3Y-27.71%
EPS 5YN/A
EPS Q2Q%11.67%
Revenue 1Y (TTM)3.63%
Revenue growth 3Y2.4%
Revenue growth 5Y1.26%
Sales Q2Q%1.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

NAD is valuated quite expensively with a Price/Earnings ratio of 61.24.
Compared to an average S&P500 Price/Earnings ratio of 27.54, NAD is valued quite expensively.
Industry RankSector Rank
PE 61.24
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 9.56
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.35%, NAD is a good candidate for dividend investing.
NAD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 6.35%

5.2 History

The dividend of NAD decreases each year by -6.94%.
NAD has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of NAD decreased recently.
Dividend Growth(5Y)-6.94%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

NAD pays out 6638.10% of its income as dividend. This is not a sustainable payout ratio.
DP6638.1%
EPS Next 2YN/A
EPS Next 3YN/A

NUVEEN QUALITY MUNICIPAL INC

NYSE:NAD (12/26/2024, 12:48:55 PM)

After market: 11.41 -0.22 (-1.93%)

11.635

+0.13 (+1.17%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)07-08 2024-07-08
Earnings (Next)01-03 2025-01-03
Inst Owners35.04%
Inst Owner Change-11.8%
Ins Owners0.02%
Ins Owner Change39.16%
Market Cap2.72B
Analysts0
Price TargetN/A
Short Float %0.18%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield 6.35%
Dividend Growth(5Y)-6.94%
DP6638.1%
Div Incr Years1
Div Non Decr Years1
Ex-Date12-13 2024-12-13 (0.0755)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 61.24
Fwd PE N/A
P/S 12.27
P/FCF 9.56
P/OCF 9.56
P/B 0.55
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)0.19
EY1.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.22
FCFY10.47%
OCF(TTM)1.22
OCFY10.47%
SpS0.95
BVpS21.29
TBVpS21.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.04%
ROE 0.04%
ROCE 2.56%
ROIC 2.02%
ROICexc 2.02%
ROICexgc 2.02%
OM 58.4%
PM (TTM) 0.95%
GM 58.58%
FCFM 128.37%
ROA(3y)-3.99%
ROA(5y)-0.32%
ROE(3y)-4.3%
ROE(5y)-0.46%
ROIC(3y)2.16%
ROIC(5y)2.15%
ROICexc(3y)2.18%
ROICexc(5y)2.17%
ROICexgc(3y)2.18%
ROICexgc(5y)2.17%
ROCE(3y)2.73%
ROCE(5y)2.73%
ROICexcg growth 3Y-5.15%
ROICexcg growth 5Y-3.95%
ROICexc growth 3Y-5.16%
ROICexc growth 5Y-3.95%
OM growth 3Y-10.98%
OM growth 5Y-5.49%
PM growth 3Y-26.87%
PM growth 5YN/A
GM growth 3Y-10.95%
GM growth 5Y-5.5%
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.34
Cash Conversion N/A
Profit Quality 13533.3%
Current Ratio 2.73
Quick Ratio 2.73
Altman-Z 12.82
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.18%
EPS 3Y-27.71%
EPS 5YN/A
EPS Q2Q%11.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.63%
Revenue growth 3Y2.4%
Revenue growth 5Y1.26%
Sales Q2Q%1.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.84%
EBIT growth 3Y-8.84%
EBIT growth 5Y-4.3%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.66%
FCF growth 3Y8.4%
FCF growth 5YN/A
OCF growth 1Y61.66%
OCF growth 3Y8.4%
OCF growth 5YN/A